Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
6.20
+0.04 (0.57%)
Jan 16, 2026, 10:19 AM EST - Market open
Annexon Employees
Annexon had 100 employees as of December 31, 2024. The number of employees increased by 29 or 40.85% compared to the previous year.
Employees
100
Change (1Y)
29
Growth (1Y)
40.85%
Revenue / Employee
n/a
Profits / Employee
-$2,088,810
Market Cap
923.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 100 | 29 | 40.85% |
| Dec 31, 2023 | 71 | -9 | -11.25% |
| Dec 31, 2022 | 80 | 19 | 31.15% |
| Dec 31, 2021 | 61 | 13 | 27.08% |
| Dec 31, 2020 | 48 | 24 | 100.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANNX News
- 1 day ago - Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026 - GlobeNewsWire
- 8 days ago - Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome - GlobeNewsWire
- 8 days ago - Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Annexon: Maintaining "Buy" Rating On Second C1q Inhibitor Advancement For Geographic Atrophy - Seeking Alpha
- 2 months ago - Annexon Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million - GlobeNewsWire
- 2 months ago - Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire